Stacey Smith Will, CCRA, joins PharPoint Research as Sr. Director of Clinical Operations

PharPoint Research, an award-winning and client-focused contract research organization (CRO), welcomes Stacey Smith Will, CCRA, as its new Sr. Director of Clinical Operations.

Ms. Will joins PharPoint as the company continues to grow and engage an increasing number of biotech and pharmaceutical clients seeking personalized attention, therapeutically aligned expertise, industry-best timelines, and decentralized study options.

“Stacey’s 28 years of experience in clinical research and her diverse therapeutic background including infectious disease, rare disease, and oncology are an asset to PharPoint’s remarkable team. We’re excited to have her join PharPoint, and I know both our clients and clinical operations team will appreciate the accessible expertise, insight, and leadership she brings,” said Audra McRae, COO and co-founder of PharPoint Research.

Before joining PharPoint, Ms. Will served as a Director at global CRO IQVIA (formerly Quintiles). There, she most recently served as Director of Clinical Leads, and has also held leadership positions within the company for North American Regional R&D Solutions Operations, North American Clinical FSP, and Clinical Site Management, among other roles.

Throughout her career, Ms. Will has trained, led, and engaged high-performing organizational teams in the clinical operations space through productive oversight management and leadership development.

“I’m thrilled to join the PharPoint team.” said Ms. Will. “The excellent relationships and partnership-like philosophy PharPoint has with its clients is especially exciting to me. Plenty of CROs attempt it – and everyone talks about it – but it’s something that’s difficult to develop. At PharPoint, it’s just such a personal approach.”